Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5872 posts found.

48610088067_59be70df49_b

Anti-HIV drug PrEP has 30% lower concentration levels in pregnant African adolescents and young women

March 10, 2020 Manufacturing and Production AIDS, HIV, PrEP, PrEP HIV, insulin

Pregnant African adolescents and young women who took the HIV drug PrEP were found to have 30% lower levels of …
News
4773288007_96679a394b_b

Fast-acting mealtime insulin approved for children with diabetes in Canada

March 10, 2020 Manufacturing and Production Type 1 diabetes, diabetes, insulin, insulin pump, type 2 diabetes

Health Canada has approved Novo Nordik’s Fiasp, a faster acting mealtime insulin, for children aged 2 and above with type …
News
medium_ab

Alligator Bioscience hires Chief Financial Officer in interim capacity

March 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alligator Bioscience, pharma

Andreas Johannesson has been announced as Alligator Bioscience’s new interim Chief Financial Officer (CFO), replacing ex-CFO Per-Olof Schrewelius who it …
Appointment
lars_nieba-web-image_0

Dr Lars Nieba appointed interim Chief Executive Officer at Nordic Nanovector

March 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Nordic Nanovector has appointed Dr Lars Nieba as the interim Chief Executive Officer. He is currently the company’s Chief Technology …
Appointment
chris-thatcher-headshot_750xx1602-2136-155-0_1

Chris Thatcher to step down as President and CEO of Neuronetics

March 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Neuronetics, Inc and Chris Thatcher, the President and CEO, have mutually agreed that he will step down from his positions …
Appointment
cambridge_skyline

Biogen and Takeda forced to send employees home as coronavirus hits Massachusetts

March 9, 2020 Manufacturing and Production, Medical Communications Biogen, Takeda, coronavirus, pharma

Big pharma has been hit by the coronavirus (COVID-19) outbreak right on its doorstep, as two of the biggest names …
News
22087308493_cedb177b53_b

ACC.20 cancelled due to coronavirus fears

March 9, 2020 Manufacturing and Production, Medical Communications cardio, cardiology, cardiovascular

The American College of Cardiology has cancelled its upcoming ACC.20 event with the World Congress of Cardiology due to concerns …
News
what-is-pharmacovigilance-328154

The need for evolution in pharmacovigilance

March 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, pharma, pharmacovigilance

Pharmacovigilance is a critical function in ensuring public health, but is our current system built to tackle the challenges of …
Feature
4420456374_64a3d7e6aa_75

Top Ten most popular articles on Pharmafile.com this week

March 6, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus, wuhan coronavirus.

The coronavirus continues to threaten the global drug supply line, with disruption to the US drug production pipeline from the …
News
shutterstock_138095450

New study calculates median drug development costs at circa $1 billion

March 5, 2020 Manufacturing and Production, Research and Development, Sales and Marketing drug development, drug prices, pharma

New research has pinned a concrete figure on the perennial industry question: how much does it cost to bring a …
News
pd36-1-ksc-20170808-ph_csh01_0023

MSD’s Phase 3 study of lymphoma treatment meets primary endpoints

March 3, 2020 Manufacturing and Production B-cell lymphoma, classical Hodgkin Lymphoma, lymphoma

MSD announced that its Phase 3 study of Keytruda (pembrolizumab) for the treatment of adults with relapsed or refractory classical …
News
gilead_hq_at_stockley_park_london_2

Gilead acquires immuno-oncology firm Forty Seven in $4.9 billion deal

March 3, 2020 Manufacturing and Production, Sales and Marketing Cancer, Forty Seven, Gilead, acquisition, oncology, pharma

Gilead has revealed it is to acquire the immunology firm Forty Seven in a deal valued at $95.50 per share …
News
1024px-u

Novartis’ subsidiary Sandoz agrees to pay $195 million to settle antitrust case

March 3, 2020 Manufacturing and Production Novartis, US Courts, generic drugs, generics, price fixing, price-fixing

Novartis’ Sandoz will pay a $195 million criminal penalty to resolve charges that it conspired to price-fix, rig bids and …
News

Sanofi scores FDA approval for Sarclisa combo in relapsed, refractory multiple myeloma

March 3, 2020 Manufacturing and Production, Sales and Marketing Cancer, Sanofi, Sarclisa, multiple myeloma, pharma

Sanofi’s monoclonal antibody and CD-38 inhibitor Sarclisa (isatuximab-irfc) has been awarded marketing authorisation from the FDA in the treatment of …
News
surgery-in-hospital-clinic-and-doctors-206-small

99% of Doctors feel NHS is not ready to deal with coronavirus, new survey finds

March 3, 2020 Manufacturing and Production Boris, Chinese Coronavirus, UK Coronavirus, Wuhan Coronavirus, coronavirus

Most NHS doctors, that partcipated in a survey, feel the organization is not well prepared to deal with a major …
News
The Gateway to Local Adoption Series

Latest content

SMC accepts amivantamab and lazertinib for EGFR-positive lung cancer

May 22, 2026

BioDuro and CTI Biotechnology in preclinical drug development partnership

May 21, 2026

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

May 21, 2026

NICE recommends sotatercept for pulmonary arterial hypertension

May 20, 2026

Vetter begins construction of new injectable medicines facility

May 20, 2026